Dhampur Bio Organics Limited (DBOL)
🎯 Key Takeaways
- Dhampur Bio Organics Limited is undergoing a strategic transformation marked by financial stabilization after years of losses, driven by the sale of its non-core sugar unit and improved performance in its core bio-products business. The company has shifted from a loss-making trajectory to generating sustainable profits in continuing operations, signaling a potential turnaround phase.
- Revenue grew 13.5% QoQ to ₹719 in Q3FY25.
- ⚠️ Overreliance on one-time gains from asset sales to report profitability, which may not be sustainable.
📖 The Story
Dhampur Bio Organics Limited is undergoing a strategic transformation marked by financial stabilization after years of losses, driven by the sale of its non-core sugar unit and improved performance in its core bio-products business. The company has shifted from a loss-making trajectory to generating sustainable profits in continuing operations, signaling a potential turnaround phase. Management is focusing on operational efficiency and governance enhancements, including auditor changes and leadership continuity.
📰 What's Happening
In Q3 FY26 (ended June 30, 2026), the company finalized the sale of its Meerganj sugar unit for ₹305 crores, generating a one-time gain of ₹63.89 crores, while core operations reported a net loss of ₹13.75 crores. Despite this, consolidated revenue reached ₹918.56 crores, and total comprehensive income was ₹36.78 crores due to the gain. The Board rejected an interim dividend and appointed Grant Thornton Bharat LLP as the new internal auditor. Earlier, in Q1 FY26, revenue grew to ₹2,953.93 crores (consolidated), with PAT of ₹38.40 crores, reflecting a significant turnaround supported by operational improvements and the sugar unit sale. Management emphasized the strategic rationale behind the divestment to sharpen focus on high-margin bio-ingredients.
Source: Stock Announcements
📊 Quarterly Results (₹ Cr)
| Metric | Q4FY23 | Q1FY24 | Q2FY24 | Q3FY24 | Q4FY24 | Q1FY25 | Q2FY25 | Q3FY25 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 921 | 709 | 666 | 425 | 595 | 638 | 634 | 719 |
| Operating Profit | 118 | 43 | 20 | 11 | 86 | 34 | -8 | 15 |
| OPM % | 12.6% | 5.7% | 2.9% | -1.0% | 13.7% | 5.2% | -1.5% | 2.2% |
| Net Profit | 80 | 13 | 0 | -6 | 39 | 0 | -23 | -7 |
| EPS | ₹12.08 | ₹1.91 | ₹0.01 | ₹-0.85 | ₹5.94 | ₹0.02 | ₹-3.52 | ₹-1.03 |
The company's financial trajectory shows a clear inflection point: after years of volatility, including a loss of ₹7 crores in Q3FY25 and a near-break-even in Q1FY25, profitability emerged in Q4FY24 with ₹₹39 crores PAT. However, recent quarters reveal a shift toward one-time gains driving net income, while core operations remain volatile. The ₹38.40 crores PAT in consolidated results for Q1 FY26 was largely underpinned by the sugar unit sale, as core operations still posted losses. This suggests that while headline profits have improved, sustainable earnings growth is tied to the performance of the bio-products segment, which showed signs of stabilization with positive operating margins in prior quarters.
🔮 Management Outlook & What's Next
Management has not provided explicit forward guidance on revenue or earnings growth rates in the latest filings. However, in the context of the sugar unit sale and auditor transition, management signaled a strategic refocus on core bio-ingredients and industrial products, emphasizing operational discipline and governance improvements. The appointment of Grant Thornton as internal auditor was framed as part of enhancing financial oversight and transparency. No official projections for future quarters were disclosed in the regulatory filings, but the tone suggests confidence in sustaining profitability through core business resilience post-divestment.
Extracted from official company announcements. Not StockFin.ai's opinion.
⚖️ Peer Comparison — Agricultural Food & other Products
| Company | MCap (₹ Cr) | P/E | ROCE | ROE | D/E |
|---|---|---|---|---|---|
| TATA CONSUMER PRODUCTS LIMITED | 1.22 L Cr | 83.2 | 9.4% | 7.3% | 0.09 |
| Marico Limited | 1.09 L Cr | 67.8 | — | — | — |
| Patanjali Foods Limited | 50,036 | 30.3 | — | — | — |
| AWL Agri Business Limited | 25,958 | 21.8 | — | — | — |
| CCL Products (India) Limited | 14,906 | 54.3 | — | — | — |
| LT Foods Limited | 14,215 | 23.9 | — | — | — |
| Balrampur Chini Mills Limited | 10,897 | 26.5 | — | — | — |
| Triveni Engineering & Industries Limited | 8,190 | 38.6 | — | — | — |
| KRBL Limited | 7,756 | 17.8 | — | — | — |
| Gujarat Ambuja Exports Limited | 7,467 | 24.2 | — | — | — |
🔗 Peer Stock Analyses
⚠️ Risk Factors
1. Overreliance on one-time gains from asset sales to report profitability, which may not be sustainable. 2. Volatility in core operating margins, as seen in fluctuating OPM trends across quarters. 3. Leadership transition with the resignation of the Vice President of Operations, potentially impacting execution continuity. 4. Governance changes, including auditor replacement and CEO dual role, may introduce execution or perception risks if not managed transparently.
📋 Recent Filings
-
Announcement 15 July 2026Dhampur Bio Organics presented Q1 FY27 results showing 4.51% YoY revenue growth to ₹553.88 crores driven by Country Liquor sales, though standalone PA...
-
🔴 Financial Results 14 July 2026Dhampur Bio Organics Limited announced on July 14, 2026, that its board approved unaudited standalone and consolidated financial results for the quart...
-
🟡 Board Meeting 14 July 2026The Board approved unaudited consolidated financial results for Q3 FY2026 (ended June 30, 2026) showing revenue of **₹918.56 crores**, total expenses ...
-
share transfer 10 July 2026Dhampur Bio Organics Limited received a SEBI-mandated confirmation certificate from Alankit Assignments for the quarter ended June 30, 2026, verifying...
-
Announcement 9 July 2026Dhampur Bio Organics announced it completed the acquisition of 74% of DBION Private Limited's equity for Rs. 74,000, establishing it as a subsidiary a...
-
🔴 Announcement 1 July 2026Dhampur Bio Organics announced the resignation of Vice President of Operations Santosh Mani effective June 30, 2026, due to personal reasons, followin...
-
🟡 Board Meeting 1 July 2026No summary available
-
🟡 Board Meeting 1 July 2026Dhampur Bio Organics Limited announced its 6th AGM on July 24, 2026, where shareholders will approve the FY2025-26 audited results, declare a final di...
-
Financial Results 26 June 2026Dhampur Bio Organics Limited announced that its trading window closes on July 1, 2026, until 48 hours after the unaudited Q1 results are declared, wit...
-
🟡 Board Meeting 18 June 2026Dhampur Bio Organics completed the slump sale of its Meerganj sugar unit to Forever Global Enterprises on June 18, 2026, receiving Rs. 305 crores in p...
🧠 Analyst's Read
Dhampur Bio Organics is transitioning from a loss-making entity to a potentially profitable one, but the sustainability of this shift hinges on the performance of its core bio-ingredients business rather than one-time asset sales. Investors should monitor upcoming AGM outcomes for governance clarity and watch for signs of consistent margin improvement in continuing operations. The next earnings cycle will be critical to assess whether profitability can be maintained without further extraordinary gains.
Based on filing content and financial data. Not a recommendation.
Read the full analysis
Quarterly trends, balance sheet, cash flow, peer comparison, and AI insights — sign up free to unlock.
Sign Up Free — Unlock Full Analysis2 free AI queries per day.
Data sourced from stock announcements. Analysis generated by StockFin.ai.
For informational purposes only — not investment advice. Updated 2026-07-16.
📡 Get AI alerts when DBOL files new disclosures
Track DBOL filings, board meetings, and corporate actions. Free email alerts at 5 PM.
Track DBOL — FreeFree account · 2 AI queries/day
© 2026 StockFin.ai — AI-powered Indian stock research